EPI Program Achievements

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
L01BC07	AZACITIDINE SHILPA	G	Azacitidine - 100mg	100mg	Injectable powder	7,350,062 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
B01AD02	ACTILYSE	BioTech	Alteplase - 50mg	50mg	Injectable dry powder for solution+diluent	100,976,426 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	11,127,864 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,485,937 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
B01AC17	AGGRASTAT	B	Tirofiban hydrochloride monohydrate - 0.25mg/ml	0.25mg/ml	Injectable concentrated solution	18,280,324 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 500mg	500mg	Injectable concentrated powder for solution	78,813,513 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
B05XA31	ADDAVEN	G	Chromic chloride 6H2O - 53mcg/10ml, Copper chloride dihydrate - 1.02mg/10ml, Ferric Chloride hexahydrate - 5.40mg/10ml, Manganese chloride 4H2O - 198mcg/10ml, Potassium iodide - 166mcg/10ml, Sodium fluoride - 2.10mg/10ml		Injectable concentrate for solution	4,065,124 L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 250mcg/2ml	250mcg/2ml	Inhaltion solution with nebuliser	544,256 L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 500mcg/2ml	500mcg/2ml	Inhaltion solution with nebuliser	713,580 L.L
R03AC02	ASTHALIN	G	Salbutamol (sulfate) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	325,210 L.L
R03AL03	ANORO ELLIPTA	B	Vilanterol - 25mcg, Umeclidinium bromide - 62.5mcg		Inhalation powder	5,367,774 L.L
R03AL01	ATROVENT COMP. HFA	B	Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation		Inhalation aerosol metered dose	544,256 L.L
R03BB01	ATROVENT N	B	Ipratropium bromide - 20mcg/actuation	20mcg/actuation	Inhalation aerosol metered dose	428,686 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
D11AX18	ALMIRAL	G	Diclofenac sodium - 1% w/w	1% w/w	Gel	396,434 L.L
M02AA10	ACHONID GEL	G	Ketoprofen - 2.5%	2.5%	Gel	179,179 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
G04BE08	AMOS	G	Tadalafil - 10mg	10mg	Film, orodispersible	1,662,781 L.L
G04BE08	AMOS	G	Tadalafil - 5mg	5mg	Film, orodispersible	2,743,998 L.L

إنجازات البرنامج